Clinical Trials Browser

Phase 1/2 × Glioblastoma × Valganciclovir × Clear all

NCT06102525 2025-09-05

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Phase 1/2 Recruiting

Glioblastoma